SAN JOSE, CA – Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has completed the acquisition of MOLLI Surgical Inc., a privately held company specializing in the… Read More
VANCOUVER, BC – STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel… Read More
VANCOUVER, BC – AbCellera (Nasdaq: ABCL) announced that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies for programs in immunology, cardiovascular disease,… Read More
FDA grants priority review and assigns a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025 – Suzetrigine, an investigational non-opioid pain signal inhibitor, has the potential to… Read More
Three projects led by UBC Faculty of Medicine researchers have been awarded more than $2.2 million in federal funding as part of the Government of Canada’s Team Grant: Strengthening the Health… Read More
